Eric M Genden, MD
- PROFESSOR AND SYSTEM CHAIR | Otolaryngology
- SENIOR ASSOCIATE DEAN FOR CLINICAL AFFAIRS
- PROFESSOR | Neurosurgery
Specialties:
Ear, Nose, Throat (ENT) / Otolaryngology, Head and Neck Surgery
Eric M. Genden, MD, MHCA, FACS, is the Isidore Friesner Professor and Chair of Otolaryngology - Head and Neck Surgery, Senior Associate Dean for Clinical Affairs, and Professor of Neurosurgery and Immunology at the Icahn School of Medicine at Mount Sinai. He is Chair of Otolaryngology - Head and Neck Surgery, Executive Vice President of Ambulatory Surgery, and Director of the Head and Neck Institute at the Mount Sinai Health System.
Dr. Genden is internationally recognized as a leader and innovator in the management of oropharyngeal cancers and microvascular reconstruction of the head and neck. His clinical expertise also encompasses thyroid and parathyroid surgery. In addition to his clinical endeavors, Dr. Genden oversees a National Institutes of Health-funded basic science laboratory that studies the transplantation immune biology of the trachea and larynx. He is also co-investigator on more than a dozen clinical trials.
A thought leader in his field, Dr. Genden is a prolific author of original peer-reviewed reports, textbooks, and book chapters. He is an editor and reviewer for numerous journals, lecturing nationally and internationally on his work. Dr. Genden is a founding fellow of the International Academy of Oral Oncology, and past president of the New York Head and Neck Society.
After finishing his residency training at Washington University and Barnes-Jewish Hospital, Dr. Genden completed his fellowship training in head and neck oncology and microvascular surgery at The Mount Sinai Medical Center. Dr. Genden also earned a Master's Degree in Healthcare Administration at Harvard University.
Read More:
Mount Sinai's Department of Otolaryngology (Ear, Nose and Throat)-Head and Neck Surgery
Icahn School of Medicine’s Head and Neck Cancer Research Program
Watch Videos Featuring Dr. Genden:
About TransOral Robotic Surgery (TORS)
Prominent Head and Neck Cancers
In the News
Healthcare Administration Degree Programs: “20 Most Innovative Surgeons Alive Today”
U.S. News & World Report: “Too Many Unnecessary Thyroid Biopsies Performed, Experts Say.”
New York Daily News Daily Checkup feature: “How to Safeguard the Health of Your Thyroid.”
OncLive: “Personalizing Treatment for HPV-related Head and Neck Cancer.”
Certifications
American Board of Otolaryngology
Clinical Focus
- Dysphagia
- Esophageal Cancer
- Esophageal Stricture
- Esophagectomy
- Facial Fracture
- Fine Needle Biopsy
- Glossectomy
- Hyperparathyroidism
- Hyperthyroidism
- Laryngeal Cancer
- Laryngectomy
- Laryngitis
- Laryngoscopy
- Lymph Node Biopsy
- Melanoma
- Melanoma Removal
- Nose Fracture
- Open Reduction And Internal Fixation Surgery
- Robot-Assisted Surgery - Overview
- Septoplasty
- Skin Biopsy
- Skin Cancer
- Skin Graft
- Soft Tissue Sarcoma
- Throat Cancer
- Thyroid Cancer
- Thyroidectomy
- Tongue Cancer
Education
MD, Icahn School of Medicine at Mount Sinai
Internship, Surgery (General Surgery), Washington University School of Medicine
Residency, Otolaryngology, Barnes-Jewish Hospital
Residency, Otolaryngology, Washington University School of Medicine
Residency, Surgery (General Surgery), Washington University
Fellowship, Otolaryngology, Head And Neck Surgery, Mount Sinai Hospital
-
2004
Broyles- Maloney Award, Honorable Mention -
2003
Best Clinical Innovations Award -
2003
Head and Neck Surgery's Honor Award -
2003
Educator of the Year -
2002
Physician of the Year -
2002
Resident Research Program Presentation, First Place -
1998
Excellence in Teaching
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Genden did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.